Clinical Trial Update: Eluvia DES for the Patients with Femoropopliteal Artery Lesions.

View source ↗

Summary

This clinical trial update indicates that the Eluvia drug-eluting stent is being studied for femoropopliteal artery lesions and is currently recruiting, sponsor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• Eluvia DES (paclitaxel-eluting stent)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Vascular Diseases, Stent Complication | Status: RECRUITING